PARP1 may be an independent prognostic marker in ESCC, and PARP1 inhibition can induce cell cycle arrest at the G2/M phase through the ATM–Chk2–CDC25C pathway (38). Here, PARP1 is linked to esophageal squamous cell carcinoma.